Last updated: April 22, 2022
Sponsor: Olive View-UCLA Education & Research Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Injury
Covid-19
Respiratory Failure
Treatment
N/AClinical Study ID
NCT05228717
1590419
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with confirmed COVID-19 pneumonia as the primary diagnosis, or COVID-associated acute hypoxemic respiratory failure or hypoxia (minimum O2 requirement 3L),that are being admitted from the emergency department, who either have waiver ofconsent, give verbal consent to participate, or have next of kin give consent forparticipation.
Exclusion
Exclusion Criteria:
- age < 18 years old, pregnant patients, or patients that verbally refuse participation
Study Design
Total Participants: 240
Study Start date:
November 10, 2020
Estimated Completion Date:
June 30, 2022
Study Description
Connect with a study center
UCLA-Ronald Reagan
Los Angeles, California 90095
United StatesActive - Recruiting
Olive View-UCLA
Sylmar, California 91342
United StatesActive - Recruiting
SUNY Downstate
New York, New York 11203
United StatesActive - Recruiting
Temple University
Philadelphia, Pennsylvania 19140
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.